Your SlideShare is downloading. ×
Is Hivaids Still Exceptional
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Is Hivaids Still Exceptional

1,169
views

Published on

HIV/AIDS, AIDS exceptionalism, data,

HIV/AIDS, AIDS exceptionalism, data,

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,169
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Is HIV/AIDS still exceptional? Alan Whiteside Health Economics and HIV/AIDS Research Division, University of KwaZulu-Natal Durban Presentation to Daniel J. Evans School of Public Affairs University of Washington Monday 9th February 2009 www.heard.org.za
  • 2. Lancet editorial 18/10/08 It is time to unwind the rhetoric, and reposition the responses to HIV/AIDS as one of several important health challenges. …. UNAIDS needs to abandon AIDS exceptionalism. Actually no. AIDS is exceptional, but not everywhere!
  • 3. Key Points • The State of the Epidemic • Why AIDS is exceptional – Three waves and long periods – AIDS and the global disease burden – The hyper epidemic countries – The demographic impacts in Africa and Eastern Europe – The cost of care • Big issues
  • 4. 2007 Global HIV Infection 33 million people [30–36 million] living with HIV, 2.2
  • 5. Global numbers living with HIV and adult HIV prevalence Source: UNAIDS 2008
  • 6. Epidemic Curve: HIV, AIDS and Impact Numbers HIV prevalence Impact A2 A1 A AIDS - cumulative B B1 T1 T2 Time 27Aug01 -Report I: Epidem’gy & Lit. p. 27
  • 7. Global Baseline Death Projections (Non-Communicable Diseases) Source: Mathers and Loncar 2002, Projections of Global Mortality and Burden of Disease from 2002 to 2030, World Health Organization, Geneva, Switzerland
  • 8. Global Baseline Deaths Projections Communicable Diseases Source: Mathers and Loncar 2002, Projections of Global Mortality and Burden of Disease from 2002 to 2030, World Health Organization, Geneva, Switzerland
  • 9. Cause of Death by Income and Percentage in 2030 Ranking Low income Middle income High income World 1 Ischaemic heart Cerebrovascular Ischaemic heart Ischaemic heart disease 13.2 disease 14.4 disease 15.2 disease 13.4 2 HIV/AIDS 13.2 Ischaemic heart Cerebrovascular Cerebrovascular disease 12.7 disease 9.0 disease 10.6 3 Cerebrovascular COPD 12.0 Trachea, bronchus HIV/AIDS 8.9 disease 8.2 lung cancers 5.1 4 COPD 5.5 HIV/AIDS 6.2 Diabetes mellitus COPD 7.8 4.8 5 Lower respiratory Trachea, bronchus COPD 4.1 Lower respiratory tract infections 5.1 lung cancers 4.3 tract infections 3.5
  • 10. 2007 Global HIV Infection 33 million people [30–36 million] living with HIV, 2.2
  • 11. 2007 HIV Prevalence, African Adults (15–49) 2.8
  • 12. HIV Prevalence in Antenatal Clinic Surveys: Southern Africa Source: UNAIDS Global AIDS report 2008
  • 13. Demographic and Health Survey HIV Prevalence
  • 14. HIV and AIDS Country Population Number living with HIV/AIDS 18.8% prevalence rate Swaziland 1,200,000 225,600 USA 301,140,000 56,614,320 UK 60,776,000 11,425,888 EU 492,964,000 92,677,000
  • 15. Republican Voters in 2008 56 000 000 Number of American’s who would be infected if the USA had Swaziland's prevalence 56 614 320
  • 16. The Demographic Impacts • Young people die • Children are not born • Population decline • Falling life expectancy • Orphaning
  • 17. Population Decline: Russia & Ukraine Ukraine 5.4 population (millions) 5.2 5 Ukraine 4.8 4.6 4.4 1990 1995 2000 2002 2004 2006 year Russia 14.9 14.8 population (millions) 14.7 14.6 14.5 14.4 Russia 14.3 14.2 14.1 14 13.9 1990 1995 2000 2002 2004 2006 year Source: World bank HNP Statistics
  • 18. Ukraine
  • 19. Demographics: Population Growth
  • 20. Swaziland 2007 Preliminary Census Results Population Data (de facto) 1997 929 718 2007 912 229 There were 17 499 fewer people over 10 years Estimated for 2006 1 200 000
  • 21. Demographics: Population Growth
  • 22. Demographics: Life Expectancy
  • 23. AIDS can not be cured • People will need treatment • For life • And it is expensive
  • 24. Per capita health expenditure Country Health Expenditure Cost of ARV Per capita (USD) treatment per person/year (USD) Botswana 171 1500* Swaziland 66 168 Mozambique 11 960** Rwanda 11 400 Source: Summary country profiles for HIV/AIDS treatment scale up, WHO 2005. *ARV treatment publicly funded. Source: Introducing ARV Therapy in the Public sector in Botswana Case study, 2004. ** Mozambique offers subsidized ARV therapy at approx. 80 USD/month. Source: Provision of Antiretroviral Therapy in resource limited settings: a review of experience. WHO/DFID 2003
  • 25. Mopping the Floor while the tap is running
  • 26. Long term impacts The impact of the epidemic is still unfolding and will do so for at least a generation Lessons from climate change??
  • 27. Agriculture
  • 28. Big Issues • AIDS interest (& funding) may have peaked – Financial melt-down and recession – Global environmental change – Food availability and prices – Peak oil • Treatment challenges – Cost and Coverage – Sustainable financing • Prevention (can we and how) • Leadership and ownership (who and how)
  • 29. What needs to be done differently • Honest discussion about costs, choices, sustainability and prospects • Prevention – A reassessment of existing programmes – Ownership (leadership in Africa does not own the epidemic) – Male female dynamics – Sexual networks • Impact – Save the human capital • Leadership